Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;102:2528-2534

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoshino, Y.
Right arrow Articles by Nagai, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoshino, Y.
Right arrow Articles by Nagai, R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
Related Collections
Right arrow Restenosis
Right arrow Smooth muscle proliferation and differentiation

(Circulation. 2000;102:2528.)
© 2000 American Heart Association, Inc.


Basic Science Reports

Regulated Expression of the BTEB2 Transcription Factor in Vascular Smooth Muscle Cells

Analysis of Developmental and Pathological Expression Profiles Shows Implications as a Predictive Factor for Restenosis

Yoichi Hoshino, MD; Masahiko Kurabayashi, MD; Tsugiyasu Kanda, MD; Akira Hasegawa, MD; Hironosuke Sakamoto, MD; Ei-ichi Okamoto, MD; Keiko Kowase, MD; Noboru Watanabe, MD; Ichiro Manabe, MD; Toru Suzuki, MD; Akihiko Nakano, MD; Shin-ichi Takase, MD; Josiah N. Wilcox, PhD; Ryozo Nagai, MD

From the Second Department of Internal Medicine, Gunma University School of Medicine (Y.H., M.K., T.K., A.H., H.S., K.K.), and the Department of Cardiovascular Medicine, Saiseikai Maebashi Hospital (A.N., S.T.), Gunma; the First Department of Internal Medicine, Shinsyu University School of Medicine, Nagano (N.W.); and the Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Tokyo (I.M., T.S., R.N.), Japan; and the Department of Medicine, Emory University, Atlanta, Ga (E.O., J.N.W.)

Correspondence to Ryozo Nagai, MD, The Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail nagai-tky{at}umin.ac.jp

Background—We have previously shown BTEB2, a Krüppel-like zinc finger transcription factor, to regulate expression of the SMemb/NMHC-B gene, which has been implicated in phenotypic modulation of smooth muscle cells (SMCs). The present study was done to assess the developmental and pathological expression profiles of BTEB2 and to further evaluate the clinical relevance of BTEB2 expression in human coronary artery disease.

Methods and Results—Immunohistochemistry showed developmentally regulated expression of BTEB2 with abundant expression in fetal but not in adult aortic SMCs of humans and rabbits. In balloon-injured aortas, predominant expression of BTEB2 was seen in neointimal SMCs. Atherectomy specimens obtained from primary and restenotic lesions showed predominant expression of BTEB2 to stellate SMCs. The incidence of restenosis in primary lesions was significantly higher in lesions containing BTEB2-positive cells than in lesions without (55.6% versus 25.0%, P=0.01).

Conclusions—The present study shows that BTEB2 expression is developmentally and pathologically regulated. BTEB2 is preferentially expressed in dedifferentiated or activated SMCs. Examination of human coronary artery specimens suggests that primary lesions containing BTEB2-positive cells are associated with higher risk of restenosis than BTEB2-negative lesions. These results suggest that BTEB2 can serve as a molecular marker for phenotypic modulation of vascular SMCs.


Key Words: angioplasty • muscle, smooth • restenosis • genes




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
N. Zhu, L. Gu, H. W. Findley, C. Chen, J.-T. Dong, L. Yang, and M. Zhou
KLF5 Interacts with p53 in Regulating Survivin Expression in Acute Lymphoblastic Leukemia
J. Biol. Chem., May 26, 2006; 281(21): 14711 - 14718.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. J. Sullivan, T. H. Teal, I. P. Luttrell, K. B. Tran, M. A. Peters, and H. Wessells
Microarray analysis reveals novel gene expression changes associated with erectile dysfunction in diabetic rats
Physiol Genomics, October 17, 2005; 23(2): 192 - 205.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. W. Bateman, D. Tan, R. G. Pestell, J. D. Black, and A. R. Black
Intestinal Tumor Progression Is Associated with Altered Function of KLF5
J. Biol. Chem., March 26, 2004; 279(13): 12093 - 12101.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Miyamoto, T. Suzuki, S. Muto, K. Aizawa, A. Kimura, Y. Mizuno, T. Nagino, Y. Imai, N. Adachi, M. Horikoshi, et al.
Positive and Negative Regulation of the Cardiovascular Transcription Factor KLF5 by p300 and the Oncogenic Regulator SET through Interaction and Acetylation on the DNA-Binding Domain
Mol. Cell. Biol., December 1, 2003; 23(23): 8528 - 8541.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
I. Manabe, T. Shindo, and R. Nagai
Gene Expression in Fibroblasts and Fibrosis: Involvement in Cardiac Hypertrophy
Circ. Res., December 13, 2002; 91(12): 1103 - 1113.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Sun, X. Chen, and V. W. Yang
Intestinal-enriched Kruppel-like Factor (Kruppel-like Factor 5) Is a Positive Regulator of Cellular Proliferation
J. Biol. Chem., March 2, 2001; 276(10): 6897 - 6900.
[Abstract] [Full Text] [PDF]